Health / Health News

    Brazil scientists discover Zika virus inhibitor

    Scientists from the Oswaldo Cruz Foundation (FIOCRUZ) in Pernambuco discovered a substance that can block Zika virus. However, years of study are still necessary before the 6-methylmercaptopurine riboside (6MMPr) can be turned into a medicine and be produced in large scale.



    The tests were conducted on epithelial and neural cells of both monkeys and humans.


    The substance is believed to imitate part of the virus, which is inserted into its genome for replication. The success obtained by the specialists reached over 99%.

    The synthetic substance belongs to the Thiopurine group, along with medicines used to treat cancer. This particular type, however, was never used; FIOCRUZ researchers worked with 6MMPr in another study, to fight the virus that causes canine distemper, a dog disease.

    The tests were conducted on epithelial and neural cells of both monkeys and humans. For every thousand viruses, 996 were eliminated with the 6MMPr, which amounts to over 99%. Also found was that the higher the dose the higher its efficiency, and that the earlier the substance starts to work, the bigger its success.

    In order to fight Zika virus, the substance imitates part of the virus structure in order to “trick” it.

    According to the research coordinator, when the virus replicates its genome, it needs tiny structural blocks. For the sake of illustration, he compared the process with a brick wall. It is as if the 6MMPr was able to imitate one of the bricks, so that when Zika virus “builds” the wall, it would stop replicating.

    Furthermore, the substance proved safe for use in neural cells. It's going to have few side effects on the nervous system, because if it were more toxic it would be a negative sign. It shows just the opposite, with few toxic agents compared to epithelial cells. In epithelial cells, it's less serious. (Agência Brasil)

    AUGUST 22, 2017



    YOU MAY ALSO LIKE

    How children visually engage with others in social situations is a heritable behavior that is altered in children with autism.
    A new discovery might be useful to protect healthy intestinal cells from radiation damage from Radiotherapy.
    Heredity accounts for up to 35 percent of small intestinal carcinoid, a rare digestive cancer. The researchers examined families with a history of the disease. Because the disease has long been considered randomly occurring rather than inherited, people with a family history are not typically screened.
    ARS scientists have shown that some tree nuts, such as pistachios, actually have fewer calories than previously thought by improving the method used for estimating calories.
    Family members who live with someone with tuberculosis may be shielded against the highly infectious disease by taking vitamin A. A new study finds that many of those who develop TB are deficient in the nutrient.
    Cells within an injured mouse eye can be coaxed into regenerating neurons and those new neurons appear to integrate themselves into the eye’s circuitry, new research shows. The findings potentially open the door to new treatments for eye trauma and retinal disease.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact